llittlep	10.18632/oncotarget.19308	<http://dx.doi.org/10.18632/oncotarget.19308>; rel="canonical", <http://www.oncotarget.com/fulltext/19308>; version="vor"; rel="item"	<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:j.0="http://purl.org/dc/terms/" xmlns:j.1="http://prismstandard.org/namespaces/basic/2.1/" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:j.2="http://purl.org/ontology/bibo/" xmlns:j.3="http://xmlns.com/foaf/0.1/"><rdf:Description rdf:about="http://dx.doi.org/10.18632/oncotarget.19308"><j.0:identifier>10.18632/oncotarget.19308</j.0:identifier><j.0:date rdf:datatype="http://www.w3.org/2001/XMLSchema#date" >2017-07-17</j.0:date><j.0:isPartOf><j.2:Journal rdf:about="http://id.crossref.org/issn/1949-2553"><owl:sameAs>urn:issn:1949-2553</owl:sameAs><j.0:title>Oncotarget</j.0:title><j.1:issn>1949-2553</j.1:issn><j.2:issn>1949-2553</j.2:issn></j.2:Journal></j.0:isPartOf><j.2:doi>10.18632/oncotarget.19308</j.2:doi><j.0:title>The AKT inhibitor triciribine in combination with paclitaxel has order-specific efficacy against Zfp217-induced breast cancer chemoresistance</j.0:title><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/william-kaliney-mlsh5bnx5fle"><j.3:name>William Kaliney</j.3:name><j.3:familyName>Kaliney</j.3:familyName><j.3:givenName>William</j.3:givenName></j.3:Person></j.0:creator><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/sunil-s-badve-mlsh5bnx5fle"><j.3:name>Sunil S. Badve</j.3:name><j.3:familyName>Badve</j.3:familyName><j.3:givenName>Sunil S.</j.3:givenName></j.3:Person></j.0:creator><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/junmin-wu-mlsh5bnx5fle"><j.3:name>Junmin Wu</j.3:name><j.3:familyName>Wu</j.3:familyName><j.3:givenName>Junmin</j.3:givenName></j.3:Person></j.0:creator><j.1:volume>8</j.1:volume><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/laurie-e-littlepage-mlsh5bnx5fle"><j.3:name>Laurie E. Littlepage</j.3:name><j.3:familyName>Littlepage</j.3:familyName><j.3:givenName>Laurie E.</j.3:givenName></j.3:Person></j.0:creator><owl:sameAs rdf:resource="info:doi/10.18632/oncotarget.19308"/><owl:sameAs rdf:resource="doi:10.18632/oncotarget.19308"/><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/joseph-a-sparano-mlsh5bnx5fle"><j.3:name>Joseph A. Sparano</j.3:name><j.3:familyName>Sparano</j.3:familyName><j.3:givenName>Joseph A.</j.3:givenName></j.3:Person></j.0:creator><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/christopher-d-suarez-mlsh5bnx5fle"><j.3:name>Christopher D. Suarez</j.3:name><j.3:familyName>Suarez</j.3:familyName><j.3:givenName>Christopher D.</j.3:givenName></j.3:Person></j.0:creator><j.2:volume>8</j.2:volume><j.1:doi>10.18632/oncotarget.19308</j.1:doi><j.0:publisher>Impact Journals, LLC</j.0:publisher></rdf:Description></rdf:RDF>
